甲三甲酸诱导的泛细胞衰减:临床特征,药物错误和第三级护理中心的结果:一项回顾性单中心研究
Harshwardhan Patil1, Shiva Prasad2, Ramaswamy Subramanian3
1Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, India.
Rheumatology international
|September 24, 2025
概括
甲基诱导的胰岛素减肥是一种严重的不良事件,通常是由药物错误引起的. 早期检测和患者教育对于预防严重后果和减少死亡率至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
- 临床药理学 临床药理学
背景情况:
- 甲甲酸 (MTX) 是一种常见的疾病修饰性抗风湿药物 (DMARD) 用于炎症状况.
- 由MTX诱导的泛细胞衰减是一种严重的不良事件,具有各种潜在的原因.
- 了解其临床特征,风险因素和结果对于患者安全至关重要.
研究的目的:
- 描述MTX诱导的全细胞衰竭的临床表现,风险因素和结果.
- 为了确定药物错误在MTX诱导的泛细胞衰竭的发展中的作用.
- 分析这种不良事件的时间模式和相关死亡率.
主要方法:
- 在2015年至2024年期间,对50名被诊断患有MTX诱导的泛细胞衰竭的患者进行了回顾性分析.
- 根据特定的血清值,定义了全细胞减肥和严重的全细胞减肥.
- 分析了患者人口统计,MTX剂量,临床症状,发病时间和死亡率.
主要成果:
- 平均MTX剂量为10mg/周;52%的病例涉及药物错误.
- 在46%的患者中发生了严重的泛细胞衰竭,并与较高的死亡率 (26.1%) 有关.
- 早期发病的泛细胞衰竭 (平均2周) 与药物错误和严重程度增加有关.
结论:
- 由MTX诱导的胰岛素衰竭经常与可预防的药物错误有关.
- 早期检测,强大的患者教育和明确的剂量指南至关重要.
- 实施系统保护措施可以减轻危及生命的MTX毒性风险.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
201
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
201
Therapeutic Drug Monitoring: Overview and Classification
309
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
309
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233

